Early research (Phase 1)Study completedNCT02262910What this trial is testingStudy of ES414 in Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Aptevo Therapeutics 35
Testing effectiveness (Phase 2)Ended earlyNCT01194960What this trial is testingTroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)Who this might be right forHormone Refractory Prostate Cancer Oxford BioMedica 25
Early research (Phase 1)Study completedNCT00327288What this trial is testingSafety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsWho this might be right forNon-small Cell Lung CancerBreast CancerProstate Cancer AmpliMed Corporation 34
Large-scale testing (Phase 3)Study completedNCT00936390What this trial is testingRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 1,538
Early research (Phase 1)Active Not RecruitingNCT03523442What this trial is testingAndrogen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 19
Early research (Phase 1)Study completedNCT04628988What this trial is testingCC-90011 and Comparators in Participants With Prostate CancerWho this might be right forProstatic Neoplasms Celgene 6
Early research (Phase 1)Study completedNCT03412786What this trial is testingBcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node MetastasesWho this might be right forProstate Cancer Herlev Hospital 20
Large-scale testing (Phase 3)Study completedNCT00331773What this trial is testingRadiation Therapy in Treating Patients With Stage II Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 1,116
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253262What this trial is testingCopanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Brown University 13
Testing effectiveness (Phase 2)Looking for participantsNCT07181161What this trial is testingStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer AstraZeneca 283
Large-scale testing (Phase 3)Study completedNCT04644822What this trial is testingSafety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.Who this might be right forProstate Cancer RecurrentRecurrent Prostate Cancer Centre for Probe Development and Commercialization 100
Testing effectiveness (Phase 2)Looking for participantsNCT06970119What this trial is testingA Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate CancerWho this might be right forProstate Cancer Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Early research (Phase 1)Looking for participantsNCT05613894What this trial is testingDose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer University of Utah 33
Testing effectiveness (Phase 2)Study completedNCT01748500What this trial is testingPantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer University Health Network, Toronto 21
Testing effectiveness (Phase 2)Ended earlyNCT03763851What this trial is testingCannabis Oil and Radiation Therapy for the Management of PainWho this might be right forMetastatic Prostate CancerLung CancerBreast Cancer Tetra Bio-Pharma 100
Early research (Phase 1)Study completedNCT00559429What this trial is testingStudy of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Testing effectiveness (Phase 2)Study completedNCT01240629What this trial is testingDoxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerWho this might be right forProstate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more University of Southern California 43
Testing effectiveness (Phase 2)Looking for participantsNCT06457919What this trial is testingTinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00140400What this trial is testingPrime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer Cell Genesys 50